Targeting SARS-CoV-2 RNA-dependent RNA polymerase: An in silico drug repurposing for COVID-19 [version 1; peer review: 2 approved]

Targeting SARS-CoV-2 RNA-dependent RNA polymerase: An in silico drug repurposing for COVID-19 [version 1; peer review: 2 approved]

Background: The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), took more lives than combined epidemics of SARS, MERS, H1N1, and Ebola. Currently, the prevention and control of spread are the goals in COVID-19 management as there...

Full description

Bibliographic Details
Main Authors:	Krishnaprasad Baby, Swastika Maity, Chetan H. Mehta, Akhil Suresh, Usha Y. Nayak, Yogendra Nayak
Format:	Article
Language:	English
Published:	F1000 Research Ltd 2020-09-01
Series:	F1000Research
Online Access:	https://f1000research.com/articles/9-1166/v1

Similar Items

In Silico Drug Repurposing of Penicillins to Target Main Protease Mpro of SARS-CoV-2
by: Baby Krishnaprasad, et al.
Published: (2020-11-01)

Computational drug repurposing of Akt-1 allosteric inhibitors for non-small cell lung cancer
by: Krishnaprasad Baby, et al.
Published: (2023-05-01)

Multi-Targeting Approach in Selection of Potential Molecule for COVID-19 Treatment
by: Varalakshmi Velagacherla, et al.
Published: (2023-01-01)

Emvolio - A battery operated portable refrigerator preserves biochemical and haematological integrity of biological samples in preclinical studies [version 3; peer review: 2 approved]
by: Ashlesh Bhat, et al.
Published: (2023-09-01)

Repurposing FDA-approved drugs cetilistat, abiraterone, diiodohydroxyquinoline, bexarotene, and remdesivir as potential inhibitors against RNA dependent RNA polymerase of SARS-CoV-2: A comparative in silico perspective
by: Nahid Shahabadi, et al.
Published: (2023-01-01)

Repurposing of potential antiviral drugs against RNA-dependent RNA polymerase of SARS-CoV-2 by computational approach
by: Sivakumar Gangadharan, et al.
Published: (2022-11-01)

In silico screening of drug inhibitors of SARS-CoV-2 RNA-dependent RNA polymerase target
by: Thanh Tung Bui, et al.
Published: (2022-03-01)

An empirical investigation on the impact of attitudes towards organ donation in India [version 2; peer review: 2 approved]
by: Smitha Nayak, et al.
Published: (2023-06-01)

Interaction Analysis of T7 RNA Polymerase with Heparin and Its Low Molecular Weight Derivatives – An in Silico Approach
by: Subhomoi Borkotoky, et al.
Published: (2016-01-01)

Interaction Analysis of T7 RNA Polymerase with Heparin and Its Low Molecular Weight Derivatives – An In Silico Approach
by: Subhomoi Borkotoky, et al.
Published: (2016-08-01)

In Silico Identification and In Vitro Validation of Repurposed Compounds Targeting the RSV Polymerase
by: Eric Xu, et al.
Published: (2023-06-01)

Novel sofosbuvir derivatives against SARS-CoV-2 RNA-dependent RNA polymerase: an in silico perspective
by: Abdulwahed Alrehaily, et al.
Published: (2023-12-01)

Computationally repurposed drugs and natural products against RNA dependent RNA polymerase as potential COVID-19 therapies
by: Sakshi Piplani, et al.
Published: (2021-09-01)

An in-silico glimpse into the pH dependent structural changes of T7 RNA polymerase: a protein with simplicity
by: Subhomoi Borkotoky, et al.
Published: (2017-07-01)

In Silico Drug Repurposing in Multiple Sclerosis Using scRNA-Seq Data
by: Andrey Shevtsov, et al.
Published: (2023-01-01)

An in silico analysis of trypanosomatid RNA polymerases: insights into their unusual transcription.
by: Kelly, S, et al.
Published: (2005)

Effectiveness of antepartum breathing exercises on the outcome of labour: A randomized controlled trial [version 3; peer review: 2 approved]
by: Baby S Nayak, et al.
Published: (2023-05-01)

Drummondin E and Flinderole B are potential inhibitors of RNA-dependent RNA polymerase of SARS-CoV-2: an in silico study
by: Nahid Akhtar, et al.
Published: (2022-03-01)

Repurposing FDA-approved drugs against multiple proteins of SARS-CoV-2: An in silico study
by: Alfred Olaoluwa Akinlalu, et al.
Published: (2021-09-01)

Detection and analysis of RNA methylation [version 1; peer review: 2 approved]
by: Nigel P. Mongan, et al.
Published: (2019-04-01)

Prediction of repurposed drugs for treating lung injury in COVID-19 [version 2; peer review: 2 approved]
by: Bing He, et al.
Published: (2020-08-01)

Assessment of quality of life in patients with surgically treated maxillofacial fractures [version 2; peer review: 2 approved]
by: Srikant Gadicherla, et al.
Published: (2023-11-01)

In silico analysis and identification of honey flavonoids as potential inhibitors of SARS-CoV-2 RNA-dependent RNA polymerase and main protease
by: Muhammad Abrar Yousaf
Published: (2022-06-01)

In silico repurposing of antipsychotic drugs for Alzheimer’s disease
by: Shivani Kumar, et al.
Published: (2017-10-01)

Effectiveness of a Disease Management Program (DMP) in controlling the progression of Chronic Kidney Disease among hypertensives and diabetics. [version 3; peer review: 2 approved]
by: Baby S Nayak, et al.
Published: (2024-03-01)

Recent advances in understanding transcription termination by RNA polymerase II [version 1; referees: 2 approved]
by: Travis J. Loya, et al.
Published: (2016-06-01)

Genome sequence of Leishmania mexicana MNYC/BZ/62/M379 expressing Cas9 and T7 RNA polymerase [version 1; peer review: 2 approved, 1 approved with reservations]
by: Ulrich Dobramysl, et al.
Published: (2022-12-01)

Impact of slice thickness on reproducibility of CT radiomic features of lung tumors [version 2; peer review: 2 approved]
by: Kaushik Nayak, et al.
Published: (2023-12-01)

The structural basis for RNA specificity and Ca2+ inhibition of an RNA-dependent RNA polymerase.
by: Salgado, P, et al.
Published: (2004)

The structural basis for RNA specificity and Ca2+ inhibition of an RNA-dependent RNA polymerase.
by: Salgado, P, et al.
Published: (2004)

Molecular docking and dynamic simulations study for repurposing of multitarget coumarins against SARS-CoV-2 main protease, papain-like protease and RNA-dependent RNA polymerase
by: Mai E. Shoman, et al.
Published: (2022-03-01)

Raltegravir, Indinavir, Tipranavir, Dolutegravir, and Etravirine against main protease and RNA-dependent RNA polymerase of SARS-CoV-2: A molecular docking and drug repurposing approach
by: Purushothaman Indu, et al.
Published: (2020-12-01)

Visualization of the small RNA transcriptome using seqclusterViz [version 2; peer review: 2 approved]
by: Lorena Pantano, et al.
Published: (2019-06-01)

In silico molecular docking analysis for repurposing approved antiviral drugs against SARS-CoV-2 main protease
by: Ibrahim Khater, et al.
Published: (2021-09-01)

Discovering Potential RNA Dependent RNA Polymerase Inhibitors as Prospective Drugs Against COVID-19: An in silico Approach
by: Satabdi Saha, et al.
Published: (2021-02-01)

Genome sequence of Leishmania mexicana MNYC/BZ/62/M379 expressing Cas9 and T7 RNA polymerase [version 2; peer review: 3 approved]
by: Ulrich Dobramysl, et al.
Published: (2023-02-01)

Can Positive Emotions Predict Consumer Satisfaction in Adverse Services? [version 2; peer review: 2 approved]
by: Dr. Smitha Nayak, et al.
Published: (2024-01-01)

In silico screening of known small molecules to bind ACE2 specific RBD on Spike glycoprotein of SARS-CoV-2 for repurposing against COVID-19 [version 1; peer review: 2 approved]
by: Bharath BR, et al.
Published: (2020-07-01)

An empirical examination of customer advocacy influenced by engagement behaviour and predispositions of FinTech customers in India [version 2; peer review: 2 approved]
by: Savitha Basri, et al.
Published: (2022-05-01)

Circadian clock control of tRNA synthetases in Neurospora crassa [version 2; peer review: 2 approved]
by: Deborah Bell-Pedersen, et al.
Published: (2023-08-01)